Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nurix Therapeutics, Inc. NRIX

Set alert

Price alert · NRIX

All alert types
25.70 USD -1.10 -4.10%

At close

25.74 +0.04 +0.16%

Pre-market · Nov 3, 4:00 AM ET

Bid
25.68 × 2
Ask
25.69 × 2
25.53 Day range 26.96
11.67 52-week range 28.23
YTD
+35.48%
1 year
+98.61%
Open
26.75
Prev close
26.80
Mkt cap
2.81B
Vol
2.35M
Avg vol
1.72M
EPS
2.43
P/E
10.58
Div yield
0.00%
More statistics
Low
25.53
High
26.96
Forward P/E
-20.15
Beta
1.78
Short ratio
10.30
Inst. own
111.03%
Dividend
0.00
Ex-div date
Earnings
Jan 27, 2027
50-d avg
24.98
200-d avg
20.18
1y target
34.50

1m chart

Chart tools
Interval
1m5m15m30m

Built from the cached one-day intraday bars.

Signals (98)
NameTimeAgo
MACD: Sell SignalNov 2, 3:59 PM12 hours ago
SMA: BearishNov 2, 3:55 PM12 hours ago
SMA: BullishNov 2, 3:46 PM12 hours ago
MACD: Buy SignalNov 2, 3:46 PM12 hours ago
SMA: BullishNov 2, 3:45 PM12 hours ago
SMA: BearishNov 2, 3:40 PM12 hours ago
RSI: OversoldNov 2, 3:40 PM12 hours ago
SMA: BearishNov 2, 3:26 PM13 hours ago
SMA: BearishNov 2, 3:22 PM13 hours ago
MACD: Sell SignalNov 2, 3:21 PM13 hours ago
RSI: OverboughtNov 2, 3:12 PM13 hours ago
MACD: Buy SignalNov 2, 2:52 PM13 hours ago
MACD: Sell SignalNov 2, 2:48 PM13 hours ago
SMA: BearishNov 2, 2:47 PM13 hours ago
SMA: BullishNov 2, 2:45 PM13 hours ago
MACD: Buy SignalNov 2, 2:43 PM13 hours ago
SMA: BullishNov 2, 2:42 PM13 hours ago
SMA: BearishNov 2, 2:32 PM13 hours ago
SMA: BearishNov 2, 2:20 PM14 hours ago
MACD: Sell SignalNov 2, 2:20 PM14 hours ago

Newest 20 of 98.

Analyst view

Consensus: none

Price target (mean) 34.50 +34.2% upside
Target (low)
25.00
Target (mean)
34.50
Target (high)
45.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
  • Strong buy5
  • Buy8
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 14
  • 2 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NRIX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.51-0.64 – 5.26-0.82+283.9%287.86M+2020.2%3
Next quarter-0.59-0.59 – -0.59-0.79+25.3%15.00M+139.9%1
Current year3.022.96 – 3.10-3.05+199.0%744.85M+786.9%3
Next year-1.28-2.48 – -0.623.02-142.2%123.22M-83.5%3

Upgrades and downgrades

The latest rating changes

NRIX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026HC Wainwright & Co.MaintainedBuyBuy
Oct 13, 2026RBC CapitalMaintainedOutperformOutperform
Oct 13, 2026OppenheimerMaintainedOutperformOutperform
Oct 13, 2026Truist SecuritiesMaintainedBuyBuy
Oct 13, 2026BairdMaintainedOutperformOutperform
Oct 13, 2026NeedhamReiteratedBuyBuy
Aug 10, 2026RBC CapitalMaintainedOutperformOutperform
Aug 4, 2026NeedhamReiteratedBuyBuy
Jul 28, 2026Morgan StanleyMaintainedOverweightOverweight
Jul 22, 2026UBSMaintainedBuyBuy
Jul 13, 2026MizuhoMaintainedOutperformOutperform
Jul 10, 2026Truist SecuritiesMaintainedBuyBuy
Jul 10, 2026RBC CapitalMaintainedOutperformOutperform
Jul 10, 2026StifelMaintainedBuyBuy
Jul 10, 2026BTIGReiteratedBuyBuy
Jul 10, 2026NeedhamReiteratedBuyBuy
Jul 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 18, 2026BairdMaintainedOutperformOutperform
Jun 15, 2026NeedhamReiteratedBuyBuy
Jun 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 9, 2026Truist SecuritiesMaintainedBuyBuy
Jun 9, 2026BTIGMaintainedBuyBuy
Jun 8, 2026JefferiesMaintainedBuyBuy
Jun 8, 2026Wells FargoMaintainedOverweightOverweight
Jun 8, 2026NeedhamMaintainedBuyBuy
May 18, 2026BTIGReiteratedBuyBuy
Apr 27, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 23, 2026NeedhamReiteratedBuyBuy
Apr 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 9, 2026Wells FargoMaintainedOverweightOverweight